The Aim of This Study is to Examine the Effects of Solution-Focused Brief Therapy (SFBT), Delivered to Students of Vocational School of Higher Education, on Hope, Problem-solving Skills, and Life Satisfaction.

NCT07432451 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-02-25

No results posted yet for this study

Summary

This randomized controlled study aims to evaluate the effects of a Solution-Focused Brief Therapy (SFBT)-based structured program on hope, problem-solving skills, and life satisfaction among students attending a university vocational school. Fifty eligible students from two campuses of a state university will be randomized to an intervention group (n=25) or a control group (n=25). The intervention group will receive a structured SFBT-based program delivered face-to-face, while the control group will continue usual conditions during the study period. Outcomes will be assessed using standardized questionnaires at baseline, post-intervention, and follow-up. The primary analyses will compare changes in outcome scores over time between groups.

Conditions

  • Psychological Well-being

Interventions

BEHAVIORAL

Solution-Focused Brief Therapy (SFBT)

"Face-to-face SFBT delivered once weekly for 6 weeks (6 sessions)."

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Principal Investigators

  • Mehtap KIZILKAYA, PhD · Aydın Adnan Menderes University, Faculty of Health Sciences, Department of Psychiatric Nursing

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2024-03-16
Completion
2025-12-22

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07432451 on ClinicalTrials.gov